| David S Sciamanna, DO | |
|
1105 6th St, Munson Medical Ctr-nicu, Traverse City, MI 49684-2349 | |
| (231) 935-5544 | |
| Not Available |
| Full Name | David S Sciamanna |
|---|---|
| Gender | Male |
| Speciality | Pediatrics - Neonatal-perinatal Medicine |
| Location | 1105 6th St, Traverse City, Michigan |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1548268808 | NPI | - | NPPES |
| 23561 | Other | MI | PRIORITY HEALTH |
| 3552810144 | Other | MI | BLUE CROSS |
| P64750 | Other | MI | BLUE CARE NETWORK |
| 4717354 | Medicaid | MI | |
| 50027456 | Other | MI | ALLIANCE HEALTH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2080N0001X | Pediatrics - Neonatal-perinatal Medicine | 5101006999 (Michigan) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| David S Sciamanna, DO 1105 6th St, Munson Medical Ctr-nicu, Traverse City, MI 49684-2349 Ph: (231) 935-5544 | David S Sciamanna, DO 1105 6th St, Munson Medical Ctr-nicu, Traverse City, MI 49684-2349 Ph: (231) 935-5544 |
News Archive
Overall rates of cancer death for both men and women have declined in the United States, and cancer incidence has remained stable among men. However, overall cancer incidence among women has increased slightly, according to a special article that appears in the October 5 issue of the Journal of the National Cancer Institute.
After close cooperation with researchers at the Norwegian Institute for Agricultural and Environmental Research (Bioforsk), Norwegian grain dealers are implementing a newly devised computational model and rapid screening tests to improve control of toxins in Norwegian cereals.
Sorrento Therapeutics, Inc. ("STI"), a privately-held and development-stage biopharmaceutical company with a proprietary technology platform for the discovery and development of human therapeutic antibodies for the treatment of a variety of disease conditions, has merged with a wholly-owned subsidiary of QuikByte Software, Inc. (OTC Bulletin Board: QBSW), a publicly-traded company with no active operations.
At the 64th ASMS Conference, Bruker announces the launch of the new rapifleX™ MALDI PharmaPulse™ (MPP) solution. It is the latest addition to Bruker's portfolio of innovative products designed to assist pharmaceutical, biotech and CRO customers to accelerate drug discovery, and rapifleX MPP can dramatically lower the cost of ultra-high throughput screening (uHTS) with further improved results.
› Verified 8 days ago
Dr. Jelanie Rae Bush, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 3537 W Front St, Suite G, Traverse City, MI 49684 Phone: 231-935-8822 Fax: 231-935-8837 | |
Cynthia Smith, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 5024 N Royal Dr, Traverse City, MI 49684 Phone: 231-935-0555 Fax: 231-935-0562 | |
Dr. Claire Ward, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 447 Munson Ave, Traverse City, MI 49686 Phone: 231-929-9090 Fax: 231-929-9092 | |
Dr. Lisa Chimner, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 3537 W Front St Ste G, Traverse City, MI 49684 Phone: 231-935-8822 Fax: 231-935-8837 | |
Jacques Burgess, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 1105 Sixth St, Traverse City, MI 49684 Phone: 231-935-5000 Fax: 231-346-6017 | |
Dr. Andrew David Tursman, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 3537 W Front St, Ste G, Traverse City, MI 49684 Phone: 231-935-8822 Fax: 231-935-8837 | |
Dr. Ann Timmermann Smith, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 7835 Truesdale Lane, Traverse City, MI 49686 Phone: 231-631-0411 |